Does the media prefer TFX or LMAT?

In the previous week, Teleflex had 4 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Teleflex and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.66 beat Teleflex's score of 1.10 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor MMED or LMAT?

In the previous week, LeMaitre Vascular had 3 more articles in the media than MiniMed Group. MarketBeat recorded 4 mentions for LeMaitre Vascular and 1 mentions for MiniMed Group. LeMaitre Vascular's average media sentiment score of 1.66 beat MiniMed Group's score of 0.00 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LeMaitre Vascular 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better valuation & earnings, LMAT or ITGR?

Integer has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LeMaitre Vascular $249.60M 7.50 $57.73M $2.85 28.72 Integer $1.84B 2.31 $102.81M $3.66 34.21

Does the media prefer LMAT or ITGR?

In the previous week, Integer had 4 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Integer and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.66 beat Integer's score of 1.42 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Integer 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LMAT or LIVN?

In the previous week, LeMaitre Vascular and LeMaitre Vascular both had 4 articles in the media. LeMaitre Vascular's average media sentiment score of 1.66 beat LivaNova's score of 0.14 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HAE or LMAT?

In the previous week, Haemonetics had 18 more articles in the media than LeMaitre Vascular. MarketBeat recorded 22 mentions for Haemonetics and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.66 beat Haemonetics' score of 0.96 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 13 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive LeMaitre Vascular 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

LeMaitre Vascular (LMAT) Competitors

$81.86 -0.46 (-0.56%)

As of 08/21/2026 04:00 PM Eastern

Compare

LMAT vs. TFX, MMED, ITGR, LIVN, and HAE

Should you buy LeMaitre Vascular stock or one of its competitors? LeMaitre Vascular's main competitors and comparable companies include Teleflex (TFX), MiniMed Group (MMED), Integer (ITGR), LivaNova (LIVN), and Haemonetics (HAE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does LeMaitre Vascular compare to Teleflex?

Teleflex (NYSE:TFX) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

LeMaitre Vascular has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	2.96	-$905.64M	-$23.29	N/A
LeMaitre Vascular	$249.60M	7.50	$57.73M	$2.85	28.72

In the previous week, Teleflex had 4 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Teleflex and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.66 beat Teleflex's score of 1.10 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

95.6% of Teleflex shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Teleflex shares are held by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. LeMaitre Vascular pays an annual dividend of $1.00 per share and has a dividend yield of 1.2%. Teleflex pays out -5.8% of its earnings in the form of a dividend. LeMaitre Vascular pays out 35.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has raised its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Teleflex has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market.

Teleflex currently has a consensus price target of $151.80, indicating a potential upside of 9.22%. LeMaitre Vascular has a consensus price target of $110.60, indicating a potential upside of 35.11%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

LeMaitre Vascular has a net margin of 25.02% compared to Teleflex's net margin of -39.67%. LeMaitre Vascular's return on equity of 15.63% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-39.67%	11.93%	5.44%
LeMaitre Vascular	25.02%	15.63%	10.06%

Summary

LeMaitre Vascular beats Teleflex on 12 of the 20 factors compared between the two stocks.

How does LeMaitre Vascular compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

LeMaitre Vascular has a net margin of 25.02% compared to MiniMed Group's net margin of 0.00%. LeMaitre Vascular's return on equity of 15.63% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
LeMaitre Vascular	25.02%	15.63%	10.06%

LeMaitre Vascular has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$3.10B	1.85	-$333M	-$0.68	N/A
LeMaitre Vascular	$249.60M	7.50	$57.73M	$2.85	28.72

84.6% of LeMaitre Vascular shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

MiniMed Group currently has a consensus price target of $21.62, indicating a potential upside of 5.70%. LeMaitre Vascular has a consensus price target of $110.60, indicating a potential upside of 35.11%. Given LeMaitre Vascular's higher possible upside, analysts plainly believe LeMaitre Vascular is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, LeMaitre Vascular had 3 more articles in the media than MiniMed Group. MarketBeat recorded 4 mentions for LeMaitre Vascular and 1 mentions for MiniMed Group. LeMaitre Vascular's average media sentiment score of 1.66 beat MiniMed Group's score of 0.00 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LeMaitre Vascular	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

LeMaitre Vascular beats MiniMed Group on 12 of the 15 factors compared between the two stocks.

How does LeMaitre Vascular compare to Integer?

LeMaitre Vascular (NASDAQ:LMAT) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

LeMaitre Vascular has a net margin of 25.02% compared to Integer's net margin of 6.97%. LeMaitre Vascular's return on equity of 15.63% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	25.02%	15.63%	10.06%
Integer	6.97%	12.79%	6.48%

Integer has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	7.50	$57.73M	$2.85	28.72
Integer	$1.84B	2.31	$102.81M	$3.66	34.21

LeMaitre Vascular has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market. Comparatively, Integer has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

LeMaitre Vascular currently has a consensus price target of $110.60, suggesting a potential upside of 35.11%. Integer has a consensus price target of $109.86, suggesting a potential downside of 12.27%. Given LeMaitre Vascular's stronger consensus rating and higher possible upside, research analysts plainly believe LeMaitre Vascular is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

In the previous week, Integer had 4 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Integer and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.66 beat Integer's score of 1.42 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Integer	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

LeMaitre Vascular beats Integer on 9 of the 16 factors compared between the two stocks.

How does LeMaitre Vascular compare to LivaNova?

LeMaitre Vascular (NASDAQ:LMAT) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

LeMaitre Vascular has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	7.50	$57.73M	$2.85	28.72
LivaNova	$1.39B	3.12	-$242.47M	$3.38	23.30

LeMaitre Vascular presently has a consensus target price of $110.60, suggesting a potential upside of 35.11%. LivaNova has a consensus target price of $83.50, suggesting a potential upside of 6.05%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55

In the previous week, LeMaitre Vascular and LeMaitre Vascular both had 4 articles in the media. LeMaitre Vascular's average media sentiment score of 1.66 beat LivaNova's score of 0.14 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LeMaitre Vascular has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

LeMaitre Vascular has a net margin of 25.02% compared to LivaNova's net margin of 12.82%. LivaNova's return on equity of 16.35% beat LeMaitre Vascular's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	25.02%	15.63%	10.06%
LivaNova	12.82%	16.35%	7.76%

Summary

LeMaitre Vascular beats LivaNova on 8 of the 15 factors compared between the two stocks.

How does LeMaitre Vascular compare to Haemonetics?

Haemonetics (NYSE:HAE) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability.

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 2.1% of Haemonetics shares are held by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LeMaitre Vascular has a net margin of 25.02% compared to Haemonetics' net margin of 7.12%. Haemonetics' return on equity of 27.55% beat LeMaitre Vascular's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
LeMaitre Vascular	25.02%	15.63%	10.06%

Haemonetics has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	3.71	$97.31M	$2.04	53.38
LeMaitre Vascular	$249.60M	7.50	$57.73M	$2.85	28.72

Haemonetics has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market.

In the previous week, Haemonetics had 18 more articles in the media than LeMaitre Vascular. MarketBeat recorded 22 mentions for Haemonetics and 4 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.66 beat Haemonetics' score of 0.96 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	13 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
LeMaitre Vascular	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Haemonetics presently has a consensus target price of $97.56, suggesting a potential downside of 10.41%. LeMaitre Vascular has a consensus target price of $110.60, suggesting a potential upside of 35.11%. Given LeMaitre Vascular's higher possible upside, analysts plainly believe LeMaitre Vascular is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
LeMaitre Vascular	0 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Haemonetics beats LeMaitre Vascular on 9 of the 17 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMAT vs. The Competition

Export

Metric	LeMaitre Vascular	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.87B	$6.02B	$7.37B	$12.85B
Dividend Yield	1.22%	1.75%	2.53%	11.08%
P/E Ratio	28.72	26.67	272.60	24.24
Price / Sales	7.50	45.38	618.96	99.81
Price / Cash	28.21	33.24	78.62	53.99
Price / Book	4.45	6.23	13.05	6.20
Net Income	$57.73M	$150.07M	$3.47B	$348.59M
7 Day Performance	-0.63%	0.69%	2.09%	0.08%
1 Month Performance	-16.03%	8.91%	6.64%	3.88%
1 Year Performance	-18.41%	8.07%	25.02%	16.98%

LeMaitre Vascular Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMAT LeMaitre Vascular	4.8766 of 5 stars	$81.86 -0.6%	$110.60 +35.1%	-18.4%	$1.87B	$249.60M	28.72	490	Positive News
TFX Teleflex	3.7644 of 5 stars	$134.60 +1.2%	$150.50 +11.8%	+7.5%	$5.97B	$1.99B	N/A	15,500	Positive News
MMED MiniMed Group	1.6748 of 5 stars	$19.56 +0.3%	$21.62 +10.5%	N/A	$5.50B	$3.10B	N/A	2,800
ITGR Integer	2.6564 of 5 stars	$125.22 +0.1%	$109.86 -12.3%	+13.2%	$4.26B	$1.84B	34.25	11,000
LIVN LivaNova	2.4671 of 5 stars	$76.86 +0.5%	$83.50 +8.6%	+40.9%	$4.23B	$1.39B	22.70	3,300	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMAT) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LeMaitre Vascular (LMAT) Competitors

LMAT vs. TFX, MMED, ITGR, LIVN, and HAE

How does LeMaitre Vascular compare to Teleflex?

Summary

How does LeMaitre Vascular compare to MiniMed Group?

Summary

How does LeMaitre Vascular compare to Integer?

Summary

How does LeMaitre Vascular compare to LivaNova?

Summary

How does LeMaitre Vascular compare to Haemonetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMAT vs. The Competition

LeMaitre Vascular Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LeMaitre Vascular (LMAT) Competitors

LMAT vs. TFX, MMED, ITGR, LIVN, and HAE

How does LeMaitre Vascular compare to Teleflex?

Which has preferable valuation & earnings, TFX or LMAT?

Does the media prefer TFX or LMAT?

Do institutionals and insiders believe in TFX or LMAT?

Is TFX or LMAT a better dividend stock?

Which has more risk and volatility, TFX or LMAT?

Do analysts rate TFX or LMAT?

Is TFX or LMAT more profitable?

Summary

How does LeMaitre Vascular compare to MiniMed Group?

Is MMED or LMAT more profitable?

Which has stronger valuation and earnings, MMED or LMAT?

Do institutionals and insiders believe in MMED or LMAT?

Do analysts rate MMED or LMAT?

Does the media favor MMED or LMAT?

Summary

How does LeMaitre Vascular compare to Integer?

Is LMAT or ITGR more profitable?

Which has better valuation & earnings, LMAT or ITGR?

Which has more risk & volatility, LMAT or ITGR?

Do analysts prefer LMAT or ITGR?

Does the media prefer LMAT or ITGR?

Do institutionals and insiders hold more shares of LMAT or ITGR?

Summary

How does LeMaitre Vascular compare to LivaNova?

Which has better earnings & valuation, LMAT or LIVN?

Do analysts rate LMAT or LIVN?

Does the media favor LMAT or LIVN?

Which has more risk & volatility, LMAT or LIVN?

Do institutionals and insiders believe in LMAT or LIVN?

Is LMAT or LIVN more profitable?

Summary

How does LeMaitre Vascular compare to Haemonetics?

Do insiders & institutionals believe in HAE or LMAT?

Is HAE or LMAT more profitable?

Which has preferable valuation and earnings, HAE or LMAT?

Which has more risk and volatility, HAE or LMAT?

Does the media favor HAE or LMAT?

Do analysts rate HAE or LMAT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMAT vs. The Competition

LeMaitre Vascular Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools